News
PRQR
1.600
-0.62%
-0.010
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), ProQR (PRQR) and OptimizeRx (OPRX)
TipRanks · 10h ago
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
TipRanks · 1d ago
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
TipRanks · 1d ago
ProQR Therapeutics Q1 EPS $(0.15), Inline, Sales $2.381M Miss $5.530M Estimate
Benzinga · 1d ago
ProQR GAAP EPS of -€0.13, revenue of €2.03M
Seeking Alpha · 1d ago
ProQR Therapeutics Q1 revenue falls and misses estimates
Reuters · 1d ago
ProQR Q1 FY26 net loss widens to € 13.4 million; cash drops to € 81.1 million
PUBT · 1d ago
BRIEF-ProQR Therapeutics Q1 EPS EUR -0.13
Reuters · 1d ago
ProQR to present Axiomer RNA editing data at upcoming scientific conferences
PUBT · 2d ago
Weekly Report: what happened at PRQR last week (0504-0508)?
Weekly Report · 2d ago
Ginkgo Bioworks Q1 revenue falls 49% on restructuring
Reuters · 5d ago
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
TipRanks · 05/04 12:27
ProQR Therapeutics announces annual shareholder meeting
PUBT · 05/04 12:06
Weekly Report: what happened at PRQR last week (0427-0501)?
Weekly Report · 05/04 09:02
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase
TipRanks · 04/30 14:04
Weekly Report: what happened at PRQR last week (0420-0424)?
Weekly Report · 04/27 09:02
Weekly Report: what happened at PRQR last week (0413-0417)?
Weekly Report · 04/20 09:02
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Lexicon Pharmaceuticals (LXRX) and Carlsmed, Inc. (CARL)
TipRanks · 04/15 12:03
Weekly Report: what happened at PRQR last week (0406-0410)?
Weekly Report · 04/13 09:02
ProQR Therapeutics: Waiting On Proof As AX-0810 Data Approaches
Seeking Alpha · 04/10 14:18
More
Webull provides a variety of real-time PRQR stock news. You can receive the latest news about Proqr Therapeuti through multiple platforms. This information may help you make smarter investment decisions.
About PRQR
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. Main purpose of the Company is advancement of its Axiomer RNA-editing platform technology. That technology uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unaddressed needs. The Company operates research pipeline that contains of RNA Therapy and AX-0810 Cholestatic Diseases (NTCP).